118 related articles for article (PubMed ID: 2196125)
1. HLA-DR expression on human peritoneal macrophages in vivo and in vitro.
Bos HJ; Keizer GD; vd Muijsenberg AJ; Beelen RH
Cell Biol Int Rep; 1990 Jun; 14(6):499-508. PubMed ID: 2196125
[TBL] [Abstract][Full Text] [Related]
2. Release of hydrogen peroxide and expression of HLA-DR and transferrin receptors by monocytes and peritoneal macrophages from patients undergoing continuous ambulatory peritoneal dialysis and normal controls.
McGregor SJ; Brock JH; Briggs JD; Junor BJ
Clin Immunol Immunopathol; 1990 Aug; 56(2):151-8. PubMed ID: 2379325
[TBL] [Abstract][Full Text] [Related]
3. Activation of immunocompetent cells in the peritoneum of patients treated with CAPD.
Davies SJ; Suassuna J; Ogg CS; Cameron JS
Kidney Int; 1989 Oct; 36(4):661-8. PubMed ID: 2811064
[TBL] [Abstract][Full Text] [Related]
4. Human peritoneal macrophages enhance HLA-DR expression in culture and are very potent stimulators of an allogeneic mixed leucocyte reaction.
Bos HJ; Kranenburg B; Beelen RH
Adv Exp Med Biol; 1988; 237():801-6. PubMed ID: 2978209
[No Abstract] [Full Text] [Related]
5. Expression of HLA class II antigens and secretion of interleukin-1 by monocytes and macrophages from adults and neonates.
Glover DM; Brownstein D; Burchett S; Larsen A; Wilson CB
Immunology; 1987 Jun; 61(2):195-201. PubMed ID: 3496273
[TBL] [Abstract][Full Text] [Related]
6. Properties of human peritoneal macrophages from continuous ambulatory peritoneal dialysis (CAPD) patients.
McGregor SJ; Brock JH; Briggs JD; Junor BJ
FEMS Microbiol Immunol; 1989 Apr; 1(5):303-4. PubMed ID: 2631872
[No Abstract] [Full Text] [Related]
7. Analysis of peritoneal macrophages in continuous ambulatory peritoneal dialysis patients.
Goldstein CS; Bomalaski JS; Zurier RB; Neilson EG; Douglas SD
Kidney Int; 1984 Nov; 26(5):733-40. PubMed ID: 6596459
[TBL] [Abstract][Full Text] [Related]
8. Long-term continuous ambulatory peritoneal dialysis reduces the expression of CD11b, CD14, CD16, and CD64 on peritoneal macrophages.
Cárcamo C; Fernández-Castro M; Selgas R; Jiménez C; Molina S; Vara F
Perit Dial Int; 1996; 16(6):582-9. PubMed ID: 8981525
[TBL] [Abstract][Full Text] [Related]
9. Difference in the blood monocyte phenotype between uremic patients and healthy controls: its relation to monocyte differentiation into macrophages in the peritoneal cavity.
Brauner A; Lu Y; Halldén G; Hylander B; Lundahl J
Inflammation; 1998 Feb; 22(1):55-66. PubMed ID: 9484650
[TBL] [Abstract][Full Text] [Related]
10. Differential abilities of human peripheral blood monocytes quantitatively or qualitatively differing in HLA-DR and HLA-DS expression to support B cell activation in liquid and semisolid cultures.
Whisler RL; Newhouse YG; Lachman LB
J Immunol; 1985 Jul; 135(1):172-9. PubMed ID: 3873488
[TBL] [Abstract][Full Text] [Related]
11. Some fixation reagents reduce or abolish the detectability of Ia-antigen and HLA-DR on cells.
Walker WS; Beelen RH; Buckley PJ; Melvin SL; Yen SE
J Immunol Methods; 1984 Feb; 67(1):89-99. PubMed ID: 6421936
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of CD25 and HLA-DR on lymphocytes recruited into the peritoneal cavity in non-infected CAPD patients.
Brauner A; Hylander B; Jacobson SH; Moshfegh A; Lundahl J
Inflammation; 2001 Dec; 25(6):399-404. PubMed ID: 11831443
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic characterization of monocytes and macrophages from CAPD patients.
Lewis SL; Norris PJ; Holmes CJ
ASAIO Trans; 1990; 36(3):M575-7. PubMed ID: 2252754
[TBL] [Abstract][Full Text] [Related]
14. Macrophage heterogeneity in man. A subpopulation of HLA-DR-bearing macrophages required for antigen-induced T cell activation also contains stimulators for autologous-reactive T cells.
Raff HV; Picker LJ; Stobo JD
J Exp Med; 1980 Sep; 152(3):581-93. PubMed ID: 6997424
[TBL] [Abstract][Full Text] [Related]
15. Reduced secretion of IL-1 beta by peritoneal cells from patients on continuous ambulatory peritoneal dialysis.
Hart PH; Jones CA; Jones KL; Finlay-Jones JJ
Immunol Cell Biol; 1993 Apr; 71 ( Pt 2)():99-107. PubMed ID: 8486401
[TBL] [Abstract][Full Text] [Related]
16. Immuno-effector characteristics of peritoneal cells during CAPD treatment: a longitudinal study.
Betjes MG; Tuk CW; Struijk DG; Krediet RT; Arisz L; Hoefsmit EC; Beelen RH
Kidney Int; 1993 Mar; 43(3):641-8. PubMed ID: 8455363
[TBL] [Abstract][Full Text] [Related]
17. Immunophenotypic characterisation of human peritoneal and alveolar macrophages and of human blood monocytes differentiated in the presence of either GM-CSF or M-CSF or a combination of GM-CSF/M-CSF.
Eischen A; Vincent F; Louis B; Schmitt-Goguel M; Bohbot A; Bergerat JP; Oberling F
Nouv Rev Fr Hematol (1978); 1992; 34(6):421-34. PubMed ID: 1300541
[TBL] [Abstract][Full Text] [Related]
18. Two-color flow cytometric analysis of the expression of MAC and MHC class II antigens on macrophages during tumor growth.
Yurochko AD; Burger CJ; Elgert KD
Cytometry; 1990; 11(6):725-35. PubMed ID: 2200657
[TBL] [Abstract][Full Text] [Related]
19. Intraperitoneal production of erythropoietin with continuous ambulatory peritoneal dialysis.
Chandra M; Clemons G; Sahdev I; McVicar M; Bluestone P
Pediatr Nephrol; 1993 Jun; 7(3):281-3. PubMed ID: 8518099
[TBL] [Abstract][Full Text] [Related]
20. Normal human peritoneal macrophages are unable to cap and internalize class II antigens.
Haskill S; Becker S; Jontell M; Sporn S; Halme J
Cell Immunol; 1988 Aug; 115(1):100-11. PubMed ID: 3401927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
